Dendritic Cell-Derived IL-6: An Instructional Regulator of Adaptive Immunity- Current Concepts and Emerging Perspectives

Article Sidebar

PDF HTML
Submitted: August 6, 2026
Published: Aug 3, 2026
DOI: 10.29328/journal.jcicm.1001059
Keywords:
Dendritic cells, IL-6, Immune polarization, T cell differentiation, Th17/Treg

Main Article Content

Hiroshi Yano
University of Redlands, Department of Biology, Redlands, CA, 92374, USA
Nathan R Wall
Center for Radiation Medicine, Loma Linda School of Medicine, USA
William HR Langridge
Loma Linda University, School of Medicine, Center for Health Disparities and Molecular Medicine, Loma Linda, CA, 92354, USA

Article Details

Yano, H., Wall, N. R., & Langridge, W. H. (2026). Dendritic Cell-Derived IL-6: An Instructional Regulator of Adaptive Immunity- Current Concepts and Emerging Perspectives. Journal of Clinical Intensive Care and Medicine, 18–24. https://doi.org/10.29328/journal.jcicm.1001059
Research Articles

Copyright (c) 2026 Yano H, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Steinman RM. Dendritic cells: understanding immunogenicity. European Journal of Immunology. 2007;37(Suppl 1):S53–S60. Available from: https://dx.doi.org/10.1002/eji.200737400.

Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392(6673):245–252. Available from: https://dx.doi.org/10.1038/32588.

Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harbor Perspectives in Biology. 2014;6(10):a016295. Available from: https://dx.doi.org/10.1101/cshperspect.a016295.

Kang S, Tanaka T, Narazaki M, Kishimoto T. Targeting interleukin-6 signaling in clinic. Immunity. 2019;50(4):1007–1023. Available from: https://dx.doi.org/10.1016/j.immuni.2019.03.026.

Rose-John S, Winthrop K, Calabrese L. The role of IL-6 in host defense against infections: immunobiology and clinical implications.Nature Reviews Rheumatology. 2017;13(7):399–409. Available from: https://dx.doi.org/10.1038/nrrheum.2017.83.

Piattini F, Sidiropoulos ND, Berest I, Kopf M. IL-6 mediates defense against influenza virus by promoting protective antibody responses but not innate inflammation. Mucosal Immunology. 2025;18(3):596–606. Available from: https://dx.doi.org/10.1016/j.mucimm.2025.02.001.

Rose-John S, Jenkins BJ, Garbers C, Moll JM, Scheller J. Targeting IL-6 trans-signaling: past, present and prospects. Nature Reviews Immunology. 2023; 23:666–681. Available from: https://dx.doi.org/10.1038/s41577-023-00856-y.

Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of Th17 cells. Nature. 2008;453(7198):1051–1057. Available from: https://dx.doi.org/10.1038/nature07036.

Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance. European Journal of Immunology. 2010;40(7):1830–1835. Available from: https://dx.doi.org/10.1002/eji.201040391.

Korn T, Mitsdoerffer M, Croxford AL, Awasthi A, Dardalhon VA, Galileos G, et al. IL-6 controls Th17 immunity in vivo by inhibiting conversion of conventional T cells into Foxp3⁺ regulatory T cells. Proceedings of the National Academy of Sciences USA. 2008;105(47):18460–18465. Available from: https://dx.doi.org/10.1073/pnas.0809850105.

Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, et al. IL-6 programs Th17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nature. 2007;448(7152):484–488. Available from: https://dx.doi.org/10.1038/nature05970.

Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, Yao Z, et al. Interleukin-2 signaling via STAT5 constrains Th17 cell generation. Nature Immunology. 2007;8(9):963–970. Available from: https://dx.doi.org/10.1038/ni1482.

Leech MD, Barr TA, Turner DG, Brown S, O’Connor RA, Gray D, Anderton SM. IL-6-dependent autoimmune disease: dendritic cells as a sufficient, but transient, source. Journal of Immunology. 2012;190(3):881–885. Available from: https://dx.doi.org/10.4049/jimmunol.1202925.

Heink S, Yogev N, Garbers C, Herwerth M, Aly L, Gasperi C, et al. Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells. Nature Immunology. 2017;18(1):74–85. Available from: https://dx.doi.org/10.1038/ni.3632.

Xu YD, Cheng M, Shang PP, Yang YQ. Role of IL-6 in dendritic cell functions. Journal of Leukocyte Biology. 2022;111(3):695–709. Available from: https://dx.doi.org/10.1002/JLB.3MR0621-616RR.

Scheller J, Garbers C, Rose-John S. Interleukin-6: from basic biology to selective blockade of pro-inflammatory activities. Seminars in Immunology. 2014;26(1):2–12. Available from: https://dx.doi.org/10.1016/j.smim.2013.11.002.

Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, et al. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17⁺ T helper cells. Cell. 2006;126(6):1121–1133. Available from: https://dx.doi.org/10.1016/j.cell.2006.07.035.

McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, McClanahan T, Cua DJ. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and mediate the development of pathogenic Th17 cells. Nature Immunology. 2009;10(1):53–60. Available from: https://dx.doi.org/10.1038/ni.1689.

Zhou L, Chong MMW, Littman DR. Plasticity of CD4⁺ T cell lineage differentiation. Immunity. 2009; 30:646–655.

Harbour SN, DiToro DF, Witte SJ, Zindl CL, Gao M, Schoeb TR, et al.

TH17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity. Science Immunology. 2020;5(49): eaaw2262. Available from: https://dx.doi.org/10.1126/sciimmunol.aaw2262.

Coombes JL, Siddiqui KR, Arancibia-Cárcamo CV, Hall J, Sun CM, Belkaid Y, Powrie F. A functionally specialized population of mucosal CD103⁺ dendritic cells induces Foxp3⁺ regulatory T cells via a TGF-β– and retinoic acid–dependent mechanism. Journal of Experimental Medicine. 2007;204(8):1757–1764. Available from: https://dx.doi.org/10.1084/jem.20070590.

Maldonado RA, von Andrian UH. How tolerogenic dendritic cells induce regulatory T cells. Advances in Immunology. 2010; 108:111–165.

Giannoukakis N. Tolerogenic dendritic cells in type 1 diabetes: no longer a concept. Frontiers in Immunology. 2023; 14:1212641. Available from: https://dx.doi.org/10.3389/fimmu.2023.1212641.

Serada S, Fujimoto M, Mihara M, Koike N, Ohsugi Y, Nomura S, et al. IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences USA. 2008;105(26):9041–9046. Available from: https://dx.doi.org/10.1073/pnas.0802218105.

Fujimoto M, Serada S, Mihara M, Uchiyama Y, Yoshida H, Koike N, et al. Interleukin-6 blockade suppresses autoimmune arthritis in mice by inhibition of inflammatory Th17 responses. Arthritis & Rheumatism. 2008;58(12):3710–3719. Available from: https://dx.doi.org/10.1002/art.24126.

Speake C, Greenbaum CJ, Bruckner JH. IL-6-targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell function. JCI Insight. 2022;7(22):e159436. Available from: https://dx.doi.org/10.1172/jci.insight.159436.

Del Fresno A, Soulat F, Roth JA, et al. Innate immune sensing and TLR4 signaling in human dendritic cells: functional plasticity without loss of maturation. Journal of Immunology. 2018;201(5):1453–1463.Available from: https://dx.doi.org/10.4049/jimmunol.1800215.

Kawai T, Akira S. TLR signaling. Cell Death and Differentiation. 2006; 13:816– 825. Available from: https://dx.doi.org/10.1038/sj.cdd.4401850.

Grebenciucova E, VanHaerents S. Interleukin-6: at the interface of human health and disease. Frontiers in Immunology. 2023; 14:1255533. Available from: https://dx.doi.org/10.3389/fimmu.2023.1255533.

Hirano T. IL-6 in inflammation, autoimmunity and cancer. International Immunology. 2021;33(3):127–148. Available from: https://dx.doi.org/10.1093/intimm/dxaa078.

Lin G, Wang J, Yang YG, Zhang Y, Sun T. Advances in dendritic cell-targeting nanodelivery systems for the induction of immune tolerance. Frontiers in Bioengineering and Biotechnology. 2023; 11:1242126. Available from: https://dx.doi.org/10.3389/fbioe.2023.1242126.

El Jamal M, Shibli F. Dendritic cell and costimulatory molecule targeted therapy for autoimmune diseases: a review of newly implemented strategies. Exploration Immunology. 2024; 4:189–210. Available from: https://dx.doi.org/10.37349/ei.2024.00136.

Zhuang Q, Cai H, Cao Q, Li Z, Liu S, Ming Y. Tolerogenic dendritic cells: the pearl of immunotherapy in organ transplantation. Frontiers in Immunology. 2020; 11:552988. Available from: https://dx.doi.org/10.3389/fimmu.2020.552988.

Russell MW, Moldoveanu Z, Ogra PL, Mestecky J. Mucosal immunity in COVID-19: a neglected but critical aspect of SARS-CoV-2 infection. Frontiers in Immunology. 2020; 11:611337. Available from: https://dx.doi.org/10.3389/fimmu.2020.611337.

Neurath MF. Targeting interleukin-6 signaling in inflammatory bowel disease and other inflammatory disorders. Nature Reviews Gastroenterology & Hepatology. 2023; 20:543–556.

Available from: https://dx.doi.org/10.1038/s41575-023-00795-0.

van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nature Reviews Molecular Cell Biology. 2018; 19:213–228.

Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nature Reviews Immunology. 2014;14(3):195–208. Available from: https://dx.doi.org/10.1038/nri3622.

Alwarawrah Y, Nichols AG, Patel I, Ball AB, MacIver NJ. Targeting IL-6 receptor mediated metabolic pathways to control Th17 cell differentiation and inflammatory responses. Frontiers in Immunology. 2025; 16:1568514. Available from: https://dx.doi.org/10.3389/fimmu.2025.1568514.

Yadav MK, Singh SP, Egwuagu CE. The IL-6/IL-12 cytokine superfamily and regulatory lymphocytes play critical roles in the etiology and suppression of CNS autoimmune diseases. Frontiers in Immunology. 2025; 16:1514080. Available from: https://dx.doi.org/10.3389/fimmu.2025.1514080.

Park E, Ciofani M. Th17 cell pathogenicity in autoimmune disease.

Experimental & Molecular Medicine. 2025;57(9):1913–1927. Available from: https://dx.doi.org/10.1038/s12276-025-01535-9.